The high cost of prescription drugs continues to burden patients and taxpayers. Surveys have shown that about three in ten adults do not take their medicines as prescribed because of the cost. Policymakers and regulators continue to explore various policies and enforcement actions to address the key drivers of high drug prices, address market distortions, and ensure patients and their families can access life-saving treatments. At the same time, challengers are actively pursuing several strategies, including litigation, that could frustrate state and federal measures that address prescription drug affordability.
